NCT lookup
Pull any trial record directly from ClinicalTrials.gov.
Sponsor: University of California, Los Angeles
Conditions: COVID-19, Post Acute Sequelae of COVID-19, Long COVID, Organ Dysfunction Syndrome, Multiple, Frailty Syndrome
Interventions: Blood and nasal swab sampling
Countries: United States
Severe acute respiratory syndrome coronavirus 2-mediated coronavirus disease (COVID-19) is an evolutionarily unprecedented natural experiment that causes major changes to the host immune system. We propose to develop a test that accurately predicts short- and long-term (within one-year) outcomes in hospitalized COVID-19 patients broadly reflecting US demographics who are at increased risk of adverse outcomes from COVID-19 using both clinical and molecular data. We will enroll patients from a hospitalized civilian population in one of the country's largest metropolitan areas and a representative National Veteran's population.
Sex: ALL
Age: 18 Years to —
Healthy volunteers: No
Study type: OBSERVATIONAL
Inclusion Criteria: * Symptomatic COVID-19 infection with hospital admission * Age 18 and above * Informed consent Exclusion Criteria: * Absence of symptomatic COVID-19 infection with hospital admission * Age 17 or below * No informed consent
- Los Angeles, California, United States
- Los Angeles, California, United States
- Sylmar, California, United States
- Torrance, California, United States
- Decatur, Georgia, United States
- The Bronx, New York, United States
- Houston, Texas, United States